I think people see stocks below a dollar and jump on
I think people see stocks below a dollar and jump on without any due diligence.
Same with our stock to a certain extent. People jumped on because they 'heard' from someone somewhere that we could be getting approval any minute. The PR came out. It did not say the words approval... Time to move on to the next shiny object like a raccoon at a campground.
The fed has flooded the market with interest free dollars... some end up in bitcoin, some end up in amazon and some in end up trying to catch the next novavax at just the right moment...
It's a carousel of 'free' money chasing a lottery ticket
I for one like the buying opportunity that has presented itself... Even if we have bad results we go to what a $1.50??? Ok, another buying opportunity while I wait for HIV approval.
And, for the record our results could not be any worse than any of the therapeutics that have already received FDA endorsement, and if they are at least our 'worthless' drug doesn't have any side effects...
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...
Continue Reading
Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...
Continue Reading
Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...
Continue Reading
The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...
Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....
Continue Reading